Cited by 273Liver Disease Diagnosis and TreatmentUltrasound Imaging and ElastographyLiver Disease and Transplantation

Transient elastography (FibroScan ® ) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?

Open access
Mikolasevic, Ivana, Orlic, Lidija, Franjic, Neven, Hauser, Goran, Stimac, Davor, Milic, Sandra·2016·World Journal of Gastroenterology

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. Currently, the routinely used modalities are unable to adequately determine the levels of steatosis and fibrosis (laboratory tests and ultrasonography) or cannot be applied as a screening procedure (liver biopsy). Among the non-invasive tests, transient elastography (FibroScan(®), TE) with controlled attenuation parameter (CAP) has demonstrated good accuracy in quantifying the levels of liver steatosis and fibrosis in patients with NAFLD, the factors associated with the diagnosis and NAFLD progression. The method is fast, reliable and reproducible, with good intra- and interobserver levels of agreement, thus allowing for population-wide screening and disease follow-up. The initial inability of the procedure to accurately determine fibrosis and steatosis in obese patients has been addressed with the development of the obese-specific XL probe. TE with CAP is a viable alternative to ultrasonography, both as an initial assessment and during follow-up of patients with NAFLD. Its ability to exclude patients with advanced fibrosis may be used to identify low-risk NAFLD patients in whom liver biopsy is not needed, therefore reducing the risk of complications and the financial costs.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3748/wjg.v22.i32.7236

Cites

131 of 131 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • With VCTE, liver stiffness measurement and controlled attenuation parameter values are determined which allow for a relatively reliable estimation of the degree of fibrosis and steatosis, respectively.

    “With the vibration-controlled transient elastography (VCTE), liver stiffness measurement (LSM) and controlled attenuation parameter (CAP) values are determined which allow for a relatively reliable estimation of the degree of fi brosis and steatosis, respectively.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Rahman RN, Ibdah JA. Nonalcoholic fatty liver disease without cirrhosis is an emergent and independent risk factor of hepatocellular carcinoma: A population based study. Hepatology 2012; 56: 241A 118
  2. Ahmed M. Non-alcoholic fatty liver disease in 2015. World J Hepatol 2015; 7: 1450-1459 [PMID: 26085906 DOI: 10.4254/wjh. v7.i11] 126 · DOI

Cited by

Sorted by citations

Authors
Mikolasevic, I., Orlic, L., Franjic, N., Hauser, G., Stimac, D., & Milic, S.
Affiliations
University of Rijeka (HR)
Venue
World Journal of Gastroenterology
Published
2016
Volume
22
Issue
32
Pages
7236
ISSN
1007-9327 (ISSN-L)
OpenAlex
W2509438375
Cited by
273
References
131
Citations by year
2026: 18 · 2025: 31 · 2024: 27 · 2023: 35 · 2022: 28 · 2021: 38 · 2020: 36 · 2019: 29 · 2018: 19 · 2017: 11
FWCI
2.66
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • World Journal of Gastroenterology (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Ultrasound Imaging and Elastography
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Keywords
transient elastography, controlled attenuation parameter, non-alcoholic fatty liver disease, hepatic steatosis, liver fibrosis, noninvasive fibrosis assessment, NAFLD screening, obesity, liver biopsy alternative, disease progression
MeSH terms
Humans, Liver, Obesity, Metabolic Syndrome, Elasticity Imaging Techniques, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review